Navigation Links
Spherix Announces 2008 Financial Results
Date:3/30/2009

03 3,408,015 Loss from continuing operations (5,618,527) (5,851,068) Discontinued operations Income from discontinued operations 2,070,091 9,136,047 Income tax expense (587,098) (4,223,353) Income from discontinued operations 1,482,993 4,912,694 Net loss $(4,135,534) $(938,374) Net (loss) income per share, basic Continuing operations $(0.39) $(0.41) Discontinued operations $0.10 $0.35 Net (loss) income per share, basic $(0.29) $(0.07) Net (loss) income per share, diluted Continuing operations $(0.39) $(0.41) Discontinued operations $0.10 $0.35 Net (loss) income per share, diluted $(0.29) $(0.07) Weighted average shares outstanding, basic 14,342,953 14,215,289 Weighted average shares outstanding, diluted 14,342,953 14,215,289
                                 Spherix Incorporated
                             Consolidated Balance Sheets
                           As of December 31, 2008 and 2007

     ASSETS                                              2008         2007
     Current assets
       Cash and cash equivalents                     $9,404,843  $15,839,959
       Short-term investments                         1,894,434            -
       Trade accounts receivable                        281,342       38,581
       Other receivables                                 37,223      167,229
       Prepaid expenses and other assets                282,971      372,242
                 Total current assets                11,900,813   16,418,011

     P
'/>"/>
SOURCE Spherix Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Spherix Reports 3rd Quarter Earnings
3. Spherix Reports 2007 Financial Results
4. Spherix Hires Key Employees
5. Spherix Holds Annual Shareholders Meeting
6. Spherix Reports 1st Quarter Earnings
7. Spherix Receives NASDAQ Bid Price Deficiency Letter
8. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
9. Spherix Transfers Stock Listing to Nasdaq Capital Market
10. Spherix Reports 3rd Quarter Earnings
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer health ... EmblemHealth , the New York -based ... RedBrick Compass health assessment, combined with the RedBrick Journeys ... EmblemHealth is among the first health plans in the ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... WALTHAM, Mass., Nov. 10, 2011 Interleukin Genetics, Inc. ... the third quarter ended September 30, 2011. Total ... $765,000, compared to $545,000 for the same period in the ... revenue. Research and development expenses were $325,000 ...
... Inc., a global, full-service testing laboratory with more than ... organs, cells, tissues and implantable biologic products and devices, ... private companies, as judged by the annual ColoradoBiz ... Top 250 Private Companies list is an annual ranking ...
... England Biolabs (NEB), in its continuing commitment to open ... database covering DNA polymerase biochemistry, genetics and structural biology. ... and maintained by NEB), Polbase summarizes the information that ... it easy for researchers to interrogate and use. Polbase ...
Cached Biology Technology:Interleukin Genetics Reports Third Quarter 2011 Financial Results 2Interleukin Genetics Reports Third Quarter 2011 Financial Results 3Interleukin Genetics Reports Third Quarter 2011 Financial Results 4LABS, Inc. Among Colorado's Top Private Companies 2New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers 2
(Date:7/9/2014)... era of increasing concern about the prevalence of ... a promising new pathway to disabling disease: blocking ... The scientists showed how bacterial siderophore, a small ... to fan bacterial growth as well as ... this infection process. Their findings appear in a ...
(Date:7/9/2014)... many backyard cooks are turning to more healthful alternatives ... fat can sometimes mean low satisfaction. Now researchers are ... low-fat wieners that are made with olive oil rather ... Journal of Agricultural and Food Chemistry . , ... have come to expect just the right amount of ...
(Date:7/9/2014)... fossil from China challenges the commonly held belief that ... ability to fly. The birdlike fossil is actually not ... remains of a tiny tree-climbing animal that could glide, ... in Blanding, Utah, and Alan Feduccia of the University ... Journal of Ornithology . , The fossil of the ...
Breaking Biology News(10 mins):Bacteria hijack plentiful iron supply source to flourish 2Researchers declassify dinosaurs as being the great-great-grandparents of birds 2
... American Society for Microbiology (ASM) USFCC/J. Roger Porter ... Ph.D., Professor Emeritus, Center for Ecology and Evolutionary ... efforts by a scientist who has demonstrated the ... stewardship activities for a major resource used by ...
... ATLANTA Humans, from ancient exchanges of food to modern ... they couldn,t achieve on their own. It,s the basis of the ... each party will receive a payoff in return for taking a ... the recent collapse of the housing market, the economy slows. ...
... muscle wasting that afflicts cancer or AIDS patients, the body ... liberate amino acids. In a new study published online June ... the Journal of Cell Biology ( www.jcb.org ), ... is a more ordered process than was previously thought. These ...
Cached Biology News:Researchers shed light on trading behavior in animals -- and humans 2Muscle atrophy through thick but not thin 2
Adhesion Molecule Antibodies...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Anti-Bcl-G (CT) Host: rabbit polyclonal Species Reactivity: human, mouse, rat Applications: WB, IHC Storage: 4C...
Anti-Mouse IgM Heavy Chain:FITC, Clone LO-MM-9, Monoclonal Antibody...
Biology Products: